Equibles does not estimate personal net worth.
Get an email with a short summary when Acumen Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get ABOS alertsDan is recorded as CEO at Acumen Pharmaceuticals, Inc. (ABOS). Dan has spoken on 1 investor event across 1 company, most recently for Acumen Pharmaceuticals, Inc. on September 10, 2026. Acumen Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Acumen Pharmaceuticals, Inc. includes Daniel O'Connell (CEO), Dr. George Golumbeski (Chairman and Board Member), Matthew Zuga (CFO) and 2 others.
“Yeah, it's an exciting time for us in the Alzheimer's space, principally as the market continues to develop and reflect the broad and large unmet need of the growing Alzheimer's population.”
Biotechnology · Healthcare
CEO
